CLINICAL TRIALS PROFILE FOR CABERGOLINE
✉ Email this page to a colleague
All Clinical Trials for CABERGOLINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00033111 ↗ | A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 | Completed | University of California, Los Angeles | Phase 2 | 2001-06-01 | The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence |
NCT00033111 ↗ | A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2001-06-01 | The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence |
NCT00129181 ↗ | Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease | Completed | GE Healthcare | N/A | 2005-01-01 | This study investigates whether there is a change in 123iodine-2ß- carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with levodopa compared to either dopamine agonist or placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CABERGOLINE
Condition Name
Clinical Trial Locations for CABERGOLINE
Trials by Country
Clinical Trial Progress for CABERGOLINE
Clinical Trial Phase
Clinical Trial Sponsors for CABERGOLINE
Sponsor Name